In the second group of 21 COVID-19 patients with G6PD, tests were conducted on PT (47.62%), PTT (33.33%), fibrinogen (19.05%), total bilirubin (76.19%), ferritin (76.19%), aspartate aminotransferase (76.19%), and alanine aminotransferase (66.67%). This evidence concerns the gene GPT and COVID-19.